Autoimmunity, inflammation, and psychosis: A search for peripheral markers

Biological Psychiatry

Volumn 75, Issue 4, 2014, Pages 324-331

  Bergink, Veerle ^a   Gibney, Sinead M ^a   Drexhage, Hemmo A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Autoimmunity; biomarkers; bipolar; inflammation; microglia; postpartum psychosis; schizophrenia

Indexed keywords

BIOLOGICAL MARKER; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA;

AFFECTIVE PSYCHOSIS; AUTOIMMUNITY; CHRONIC INFLAMMATION; COMORBIDITY; EARLY LIFE STRESS; ENVIRONMENTAL STRESS; GENE EXPRESSION; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; INFECTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MACROPHAGE ACTIVATION; MATERNAL STRESS; MICROGLIA; MONOCYTE; MONOCYTOSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; T LYMPHOCYTE; TH1 CELL;

AUTOIMMUNITY; BIOMARKERS; BIPOLAR; INFLAMMATION; MICROGLIA; POSTPARTUM PSYCHOSIS; SCHIZOPHRENIA;

ANIMALS; AUTOIMMUNITY; BIOLOGICAL MARKERS; CYTOKINES; HUMANS; INFLAMMATION; MICROGLIA; MONOCYTES; PSYCHOTIC DISORDERS; T-LYMPHOCYTES;

EID: 84892585004     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.09.037     Document Type: Review

References (104)

1. R.H. Yolken, and E.F. Torrey Are some cases of psychosis caused by microbial agents? A review of the evidence Mol Psychiatry 13 2008 470 479
2. M.E. Benros, P.R. Nielsen, M. Nordentoft, W.W. Eaton, S.O. Dalton, and P.B. Mortensen Autoimmune diseases and severe infections as risk factors for schizophrenia: A 30-year population-based register study Am J Psychiatry 168 2011 1303 1310
3. D.M. Lawrence, and E.O. Major HIV-1 and the brain: Connections between HIV-1-associated dementia, neuropathology and neuroimmunology Microbes Infect 4 2002 301 308
4. M.L. Block, and J.S. Hong Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism Prog Neurobiol 76 2005 77 98
5. B. Dube, T. Benton, D.G. Cruess, and D.L. Evans Neuropsychiatric manifestations of HIV infection and AIDS J Psychiatry Neurosci 30 2005 237 246
6. C.K. Petito, J.E. Torres-Munoz, F. Zielger, and M. McCarthy Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome J Neurovirol 12 2006 272 283
7. C.J. Carter Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: Cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii Schizophr Bull 35 2009 1163 1182
8. G.K. Bertsias, J.P. Ioannidis, M. Aringer, E. Bollen, S. Bombardieri, and I.N. Bruce et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: Report of a task force of the EULAR standing committee for clinical affairs Ann Rheum Dis 69 2010 2074 2082
9. T. Gabelic, I. Adamec, A. Mrden, M. Rados, V.V. Brinar, and M. Habek Psychotic reaction as a manifestation of multiple sclerosis relapse treated with plasma exchange Neurol Sci 33 2012 379 382
10. E.M. Chastain, and S.D. Miller Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease Immunol Rev 245 2012 227 238
11. N.R. Rose, and C. Bona Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today 14 1993 426 430
12. A.Y. Yu, and F.G. Moore Paraneoplastic encephalitis presenting as postpartum psychosis Psychosomatics 52 2011 568 570
13. H.S. Shaaban, H.F. Choo, and J.W. Sensakovic Anti-NMDA-receptor encephalitis presenting as postpartum psychosis in a young woman, treated with rituximab Ann Saudi Med 32 2012 421 423
14. I.S. Haussleiter, B. Emons, M. Schaub, K. Borowski, M. Brune, K.P. Wandinger, and G. Juckel Investigation of antibodies against synaptic proteins in a cross-sectional cohort of psychotic patients Schizophr Res 140 2012 258 259
15. J. Steiner, M. Walter, W. Glanz, Z. Sarnyai, H.G. Bernstein, and S. Vielhaber et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis JAMA Psychiatry 70 2013 271 278
16. A. Ganguli, R. Fitzgerald, L. Walker, M. Beadsworth, and H.C. Mwandumba Voltage-gated, potassium-channel antibody-associated limbic encephalitis presenting as acute psychosis J Neuropsychiatry Clin Neurosci 23 2011 E32 E34
17. L. Tebartz van Elst, S. Kloppel, and S. Rauer Voltage-gated potassium channel/LGI1 antibody-associated encephalopathy may cause brief psychotic disorder J Clin Psychiatry 72 2011 722 723
18. J.F. Ludvigsson, U. Osby, A. Ekbom, and S.M. Montgomery Coeliac disease and risk of schizophrenia and other psychosis: A general population cohort study Scand J Gastroenterol 42 2007 179 185
19. W.W. Eaton, M.G. Pedersen, P.R. Nielsen, and P.B. Mortensen Autoimmune diseases, bipolar disorder, and non-affective psychosis Bipolar Disord 12 2010 638 646
20. C.P. Carney, and L.E. Jones Medical comorbidity in women and men with bipolar disorders: A population-based controlled study Psychosom Med 68 2006 684 691
21. F. Cassidy, E. Ahearn, and B.J. Carroll Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients Am J Psychiatry 156 1999 1417 1420
22. R. van Winkel, M. De Hert, D. Van Eyck, L. Hanssens, M. Wampers, A. Scheen, and J. Peuskens Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder Bipolar Disord 10 2008 342 348
23. R.C. Padmos, L. Bekris, E.M. Knijff, H. Tiemeier, R.W. Kupka, and D. Cohen et al. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder Biol Psychiatry 56 2004 476 482
24. R.W. Kupka, W.A. Nolen, R.M. Post, S.L. McElroy, L.L. Altshuler, and K.D. Denicoff et al. High rate of autoimmune thyroiditis in bipolar disorder: Lack of association with lithium exposure Biol Psychiatry 51 2002 305 311
25. D.K. Sokol, R.S. O'Brien, D.R. Wagenknecht, T. Rao, and J.A. McIntyre Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis J Neuroimmunol 190 2007 151 156
26. F. Dickerson, C. Stallings, A. Origoni, C. Vaughan, S. Khushalani, and F. Leister et al. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia Biol Psychiatry 68 2010 100 104
27. F. Dickerson, C. Stallings, A. Origoni, C. Vaughan, S. Khushalani, and R. Yolken Markers of gluten sensitivity in acute mania: A longitudinal study Psychiatry Res 196 2012 68 71
28. M.H. Hillegers, C.G. Reichart, M. Wals, F.C. Verhulst, J. Ormel, W.A. Nolen, and H.A. Drexhage Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents Eur Neuropsychopharmacol 17 2007 394 399
29. R. Vonk, A.C. van der Schot, R.S. Kahn, W.A. Nolen, and H.A. Drexhage Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? Biol Psychiatry 62 2007 135 140
30. D.L. Mueller Mechanisms maintaining peripheral tolerance Nat Immunol 11 2010 21 27
31. L. de Haan, R. Klaassen, N. van Beveren, L. Wunderink, B.P. Rutten, and J. van Os [Psychotic disorders: The need for staging] Tijdschr Psychiatr 54 2012 927 933
32. R.E. Kendell, J.C. Chalmers, and C. Platz Epidemiology of puerperal psychoses Br J Psychiatry 150 1987 662 673
33. J.P. Buyon The effects of pregnancy on autoimmune diseases J Leukoc Biol 63 1998 281 287
34. A.P. Weetman Immunity, thyroid function and pregnancy: Molecular mechanisms Nat Rev Endocrinol 6 2010 311 318
35. T. Haupl, M. Ostensen, A. Grutzkau, G.R. Burmester, and P.M. Villiger Interaction between rheumatoid arthritis and pregnancy: Correlation of molecular data with clinical disease activity measures Rheumatology (Oxford) 47 suppl 3 2008 iii19 iii22
36. G. Ruiz-Irastorza, F. Lima, J. Alves, M.A. Khamashta, J. Simpson, G.R. Hughes, and N.M. Buchanan Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies Br J Rheumatol 35 1996 133 138
37. C. Confavreux, M. Hutchinson, M.M. Hours, P. Cortinovis-Tourniaire, and T. Moreau Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group N Engl J Med 339 1998 285 291
38. C. Schramm, J. Herkel, U. Beuers, S. Kanzler, P.R. Galle, and A.W. Lohse Pregnancy in autoimmune hepatitis: Outcome and risk factors Am J Gastroenterol 101 2006 556 560
39. K. Sliwa, J. Fett, and U. Elkayam Peripartum cardiomyopathy Lancet 368 2006 687 693
40. E. Calcagni, and I. Elenkov Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases Ann N Y Acad Sci 1069 2006 62 76
41. N. Gleicher Postpartum depression, an autoimmune disease? Autoimmun Rev 6 2007 572 576
42. V. Bergink, K.M. Burgerhout, K. Weigelt, V.J. Pop, H. de Wit, and R.C. Drexhage et al. Immune system dysregulation in first-onset postpartum psychosis Biol Psychiatry 73 2013 1000 1007
43. F. Alliot, I. Godin, and B. Pessac Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain Brain Res Dev Brain Res 117 1999 145 152
44. W.Y. Chan, S. Kohsaka, and P. Rezaie The origin and cell lineage of microglia: New concepts Brain Res Rev 53 2007 344 354
45. F. Ginhoux, M. Greter, M. Leboeuf, S. Nandi, P. See, and S. Gokhan et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages Science 330 2010 841 845
46. F. Ginhoux, S. Lim, G. Hoeffel, D. Low, and T. Huber Origin and differentiation of microglia Front Cell Neurosci 7 2013 45
47. H. Kettenmann, U.K. Hanisch, M. Noda, and A. Verkhratsky Physiology of microglia Physiol Rev 91 2011 461 553
48. A. Monji, T.A. Kato, Y. Mizoguchi, H. Horikawa, Y. Seki, and M. Kasai et al. Neuroinflammation in schizophrenia especially focused on the role of microglia Prog Neuropsychopharmacol Biol Psychiatry 42 2013 115 121
49. J. Steiner, H. Bielau, R. Brisch, P. Danos, O. Ullrich, and C. Mawrin et al. Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide J Psychiatr Res 42 2008 151 157
50. J. Steiner, C. Mawrin, A. Ziegeler, H. Bielau, O. Ullrich, H.G. Bernstein, and B. Bogerts Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization Acta Neuropathol 112 2006 305 316
51. S.E. Arnold, J.Q. Trojanowski, R.E. Gur, P. Blackwell, L.Y. Han, and C. Choi Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia Arch Gen Psychiatry 55 1998 225 232
52. T.A. Bayer, R. Buslei, L. Havas, and P. Falkai Evidence for activation of microglia in patients with psychiatric illnesses Neurosci Lett 271 1999 126 128
53. E. Falke, L.Y. Han, and S.E. Arnold Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia Psychiatry Res 93 2000 103 110
54. K. Radewicz, L.J. Garey, S.M. Gentleman, and R. Reynolds Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics J Neuropathol Exp Neurol 59 2000 137 150
55. T. Togo, H. Akiyama, H. Kondo, K. Ikeda, M. Kato, E. Iseki, and K. Kosaka Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases Brain Res 885 2000 117 121
56. T. Wierzba-Bobrowicz, E. Lewandowska, E. Kosno-Kruszewska, W. Lechowicz, E. Pasennik, and B. Schmidt-Sidor Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics Folia Neuropathol 42 2004 157 165
57. T. Wierzba-Bobrowicz, E. Lewandowska, W. Lechowicz, T. Stepien, and E. Pasennik Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics Folia Neuropathol 43 2005 81 89
58. S. Busse, M. Busse, K. Schiltz, H. Bielau, T. Gos, and R. Brisch et al. Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: Further evidence for disease course-related immune alterations? Brain Behav Immun 26 2012 1273 1279
59. S.G. Fillman, N. Cloonan, V.S. Catts, L.C. Miller, J. Wong, and T. McCrossin et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia Mol Psychiatry 18 2013 206 214
60. B. Dean, A.S. Gibbons, N. Tawadros, L. Brooks, I.P. Everall, and E. Scarr Different changes in cortical tumor necrosis factor-alpha-related pathways in schizophrenia and mood disorders Mol Psychiatry 18 2013 767 773
61. J. Doorduin, E.F. de Vries, A.T. Willemsen, J.C. de Groot, R.A. Dierckx, and H.C. Klein Neuroinflammation in schizophrenia-related psychosis: A PET study J Nucl Med 50 2009 1801 1807
62. B.N. van Berckel, M.G. Bossong, R. Boellaard, R. Kloet, A. Schuitemaker, and E. Caspers et al. Microglia activation in recent-onset schizophrenia: A quantitative (R)-[11C]PK11195 positron emission tomography study Biol Psychiatry 64 2008 820 822
63. R.B. Banati Visualising microglial activation in vivo Glia 40 2002 206 217
64. M. Rothermundt, V. Arolt, C. Weitzsch, D. Eckhoff, and H. Kirchner Immunological dysfunction in schizophrenia: A systematic approach Neuropsychobiology 37 1998 186 193
65. R.C. Drexhage, T.A. Hoogenboezem, D. Cohen, M.A. Versnel, W.A. Nolen, N.J. van Beveren, and H.A. Drexhage An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces Int J Neuropsychopharmacol 14 2011 746 755
66. E.P. Zorrilla, T.D. Cannon, R.E. Gur, and J. Kessler Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: Markers of vulnerability or disease? Biol Psychiatry 40 1996 825 833
67. H.V. Nikkila, K. Muller, A. Ahokas, K. Miettinen, R. Rimon, and L.C. Andersson Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes Am J Psychiatry 156 1999 1725 1729
68. R.C. Padmos, M.H. Hillegers, E.M. Knijff, R. Vonk, A. Bouvy, and F.J. Staal et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes Arch Gen Psychiatry 65 2008 395 407
69. R.C. Drexhage, L. van der Heul-Nieuwenhuijsen, R.C. Padmos, N. van Beveren, D. Cohen, and M.A. Versnel et al. Inflammatory gene expression in monocytes of patients with schizophrenia: Overlap and difference with bipolar disorder. A study in naturalistically treated patients Int J Neuropsychopharmacol 13 2010 1369 1381
70. M. Di Nicola, A. Cattaneo, N. Hepgul, M. Di Forti, K.J. Aitchison, and L. Janiri et al. Serum and gene expression profile of cytokines in first-episode psychosis Brain Behav Immun 31 2013 90 95
71. S. Theodoropoulou, G. Spanakos, C.N. Baxevanis, M. Economou, A.D. Gritzapis, M.P. Papamichail, and C.N. Stefanis Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients Schizophr Res 47 2001 13 25
72. N. Muller, J.K. Wagner, D. Krause, E. Weidinger, A. Wildenauer, and M. Obermeier et al. Impaired monocyte activation in schizophrenia Psychiatry Res 198 2012 341 346
73. S.K. Biswas, and E. Lopez-Collazo Endotoxin tolerance: New mechanisms, molecules and clinical significance Trends Immunol 30 2009 475 487
74. A. Achiron, S. Noy, E. Pras, J. Lereya, H. Hermesh, and N. Laor T-cell subsets in acute psychotic schizophrenic patients Biol Psychiatry 35 1994 27 31
75. F. Villemain, L. Chatenoud, A. Galinowski, F. Homo-Delarche, D. Ginestet, and H. Loo et al. Aberrant T cell-mediated immunity in untreated schizophrenic patients: Deficient interleukin-2 production Am J Psychiatry 146 1989 609 616
76. K. Maino, R. Gruber, M. Riedel, N. Seitz, M. Schwarz, and N. Muller T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment Psychiatry Res 152 2007 173 180
77. J. Steiner, R. Jacobs, B. Panteli, M. Brauner, K. Schiltz, and S. Bahn et al. Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity Eur Arch Psychiatry Clin Neurosci 260 2010 509 518
78. H. Bessler, Z. Levental, L. Karp, I. Modai, M. Djaldetti, and A. Weizman Cytokine production in drug-free and neuroleptic-treated schizophrenic patients Biol Psychiatry 38 1995 297 302
79. R. Ganguli, J.S. Brar, K.R. Chengappa, M. DeLeo, Z.W. Yang, G. Shurin, and B.S. Rabin Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms Arch Gen Psychiatry 52 1995 668 672
80. M. Hornberg, V. Arolt, I. Wilke, A. Kruse, and H. Kirchner Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia Schizophr Res 15 1995 237 242
81. V. Arolt, M. Rothermundt, K.P. Wandinger, and H. Kirchner Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment Mol Psychiatry 5 2000 150 158
82. M. Riedel, I. Spellmann, M.J. Schwarz, M. Strassnig, C. Sikorski, H.J. Moller, and N. Müller Decreased T cellular immune response in schizophrenic patients J Psychiatr Res 41 2007 3 7
83. R.M. Craddock, H.E. Lockstone, D.A. Rider, M.T. Wayland, L.J. Harris, P.J. McKenna, and S. Bahn Altered T-cell function in schizophrenia: A cellular model to investigate molecular disease mechanisms PLoS One 2 2007 e692
84. B.J. Miller, P. Buckley, W. Seabolt, A. Mellor, and B. Kirkpatrick Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects Biol Psychiatry 70 2011 663 671
85. A. Modabbernia, S. Taslimi, E. Brietzke, and M. Ashrafi Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies Biol Psychiatry 74 2013 15 25
86. S. Potvin, E. Stip, A.A. Sepehry, A. Gendron, R. Bah, and E. Kouassi Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review Biol Psychiatry 63 2008 801 808
87. B.I. Goldstein, D.E. Kemp, J.K. Soczynska, and R.S. McIntyre Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: A systematic review of the literature J Clin Psychiatry 70 2009 1078 1090
88. S. Hope, I. Dieset, I. Agartz, N.E. Steen, T. Ueland, and I. Melle et al. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia J Psychiatr Res 45 2011 1608 1616
89. C. Langan, and C. McDonald Neurobiological trait abnormalities in bipolar disorder Mol Psychiatry 14 2009 833 846
90. W. Beumer, R.C. Drexhage, H. De Wit, M.A. Versnel, H.A. Drexhage, and D. Cohen Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome Psychoneuroendocrinology 37 2012 1901 1911
91. S. Giovanoli, H. Engler, A. Engler, J. Richetto, M. Voget, and R. Willi et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice Science 339 2013 1095 1099
92. U. Meyer, J. Feldon, and B.K. Yee A review of the fetal brain cytokine imbalance hypothesis of schizophrenia Schizophr Bull 35 2009 959 972
93. P. Boksa Effects of prenatal infection on brain development and behavior: A review of findings from animal models Brain Behav Immun 24 2010 881 897
94. P. Boksa Maternal infection during pregnancy and schizophrenia J Psychiatry Neurosci 33 2008 183 185
95. A.S. Brown Exposure to prenatal infection and risk of schizophrenia Front Psychiatry 2 2011 63
96. J. Suvisaari, J. Haukka, A. Tanskanen, T. Hovi, and J. Lonnqvist Association between prenatal exposure to poliovirus infection and adult schizophrenia Am J Psychiatry 156 1999 1100 1102
97. S.L. Buka, T.D. Cannon, E.F. Torrey, and R.H. Yolken Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring Biol Psychiatry 63 2008 809 815
98. P.B. Mortensen, C.B. Pedersen, D.M. Hougaard, B. Norgaard-Petersen, O. Mors, A.D. Borglum, and R.H. Yolken A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring Schizophr Res 122 2010 257 263
99. J. van Os, and J.P. Selten Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands Br J Psychiatry 172 1998 324 326
100. D. Malaspina, C. Corcoran, K.R. Kleinhaus, M.C. Perrin, S. Fennig, and D. Nahon et al. Acute maternal stress in pregnancy and schizophrenia in offspring: A cohort prospective study BMC Psychiatry 8 2008 71
101. T.A. Bayer, P. Falkai, and W. Maier Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the "two hit hypothesis" J Psychiatr Res 33 1999 543 548
102. T.M. Maynard, L. Sikich, J.A. Lieberman, and A.S. LaMantia Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia Schizophr Bull 27 2001 457 476
103. R. Dantzer Cytokine, sickness behavior, and depression Neurol Clin 24 2006 441 460
104. K.V. Sathyasaikumar, E.K. Stachowski, I. Wonodi, R.C. Roberts, A. Rassoulpour, R.P. McMahon, and R. Schwarcz Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia Schizophr Bull 37 2011 1147 1156